We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The drug is currently approved for treatment of patients with multicentric Castleman disease, a rare condition that affects the lymph nodes and related tissues. Read More
Sponsors who fail to meet certain Risk Evaluation and Mitigation Strategy (REMS) requirements won’t face FDA action during the COVID-19 outbreak, the agency announced. Read More
State pharmacy boards in Idaho, Ohio, Nevada and Texas are restricting prescriptions of certain drugs that may hold potential in treating the coronavirus, including chloroquine and hydroxychloroquine, following a spike in demand. Read More
Dozens of clinical trials are being put on hold as the clinical trial industry grapples with the fallout from COVID-19. The outbreak has put the brakes on virtually all new trials being planned, except those focused on COVID-19 vaccines and treatments. Read More
The Medicines and Healthcare Products Regulatory Agency also said Friday that there is currently no research linking ibuprofen to the likelihood of contracting the virus or worsening the symptoms. Read More